MedPath

Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-10-01
Employees
1
Market Cap
-
Website
http://www.euclises.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

ECP-1014 Treatment for Patients With Solid Tumor Cancers

Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2021-06-18
Last Posted Date
2023-02-16
Lead Sponsor
Euclises Pharmaceuticals, Inc.
Target Recruit Count
29
Registration Number
NCT04930354
Locations
🇨🇳

The Sixth Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.